Tessa Straatmijer

Research output

Research output per year 2021 2023 2024

• 9 Article
• 2 Comment/Letter to the editor
• 1 Phd-Thesis - Research and graduation internal

Research output per year

Research output per year

Search results

• 2024

  Patient preferences in treatment options of ulcerative colitis: a discrete choice experiment

  Straatmijer, T., van den Akker-van Marle, M. E., Ponsioen, C. Y., van der Horst, D., Scherpenzeel, M. P. M., Duijvestein, M. & van der Meulen-de Jong, A. E., 2024, In: Scandinavian journal of gastroenterology. 59, 3, p. 288-295 8 p.

  Research output: Contribution to journal › Article › Academic › peer-review

  Open Access
• 2023

  Effectiveness and safety of tofacitinib for ulcerative colitis: two-year results of the ICC Registry

  Straatmijer, T., van Schaik, F. D. M., Bodelier, A. G. L., Visschedijk, M., de Vries, A. C., Ponsioen, C. Y., Pierik, M., van Bodegraven, A. A., West, R. L., de Boer, N. K. H., Srivastava, N., Romkens, T. E. H., Hoekstra, J., Oldenburg, B., Dijkstra, G., van der Woude, J. C., Löwenberg, M., Mujagic, Z., Biemans, V. B. C., van der Meulen-de Jong, A. E., & 1 othersDuijvestein, M., Jan 2023, In: Alimentary Pharmacology and Therapeutics. 57, 1, p. 117-126 10 p.

  Research output: Contribution to journal › Article › Academic › peer-review

  Open Access
  10 Citations (Scopus)

• Inflammatoire darmziekten

  Translated title of the contribution: Inflammatory bowel diseaseStraatmijer, T. & Duijvestein, M., 31 Aug 2023, In: Nederlands Tijdschrift voor Geneeskunde. 167

  Research output: Contribution to journal › Article › Professional

• Letter: tricky reactions to switch back from subcutaneous to intravenous vedolizumab in inflammatory bowel disease patients—authors' reply

  Volkers, A., Straatmijer, T., Duijvestein, M., Löwenberg, M., van der Meulen, A. & D'Haens, G., 1 Mar 2023, In: Alimentary Pharmacology and Therapeutics. 57, 6, p. 743-744 2 p.

  Research output: Contribution to journal › Comment/Letter to the editor › Academic

  Open Access
  2 Citations (Scopus)

• Pharmacologic treatment of inflammatory bowel disease: Real world outcomes and optimizing strategies

  Straatmijer, T., 2023, 203 p.

  Research output: PhD Thesis › Phd-Thesis - Research and graduation internal

• Reply

  Straatmijer, T., van der Meulen, A. E. & Duijvestein, M., 1 May 2023, In: Clinical Gastroenterology and Hepatology. 21, 5, p. 1373-1374 2 p.

  Research output: Contribution to journal › Comment/Letter to the editor › Academic

  Open Access

• Superior Effectiveness of Tofacitinib Compared to Vedolizumab in Anti-TNF-experienced Ulcerative Colitis Patients: A Nationwide Dutch Registry Study

  Initiative on Crohn and Colitis, Jan 2023, In: Clinical Gastroenterology and Hepatology. 21, 1, p. 182-191.e2

  Research output: Contribution to journal › Article › Academic › peer-review

  Open Access
  19 Citations (Scopus)

• Ustekinumab Trough Concentrations Are Associated with Biochemical Outcomes in Patients with Crohn’s Disease

  the Dutch Initiative on Crohn’s and Colitis (ICC), Jun 2023, In: Digestive Diseases and Sciences. 68, 6, p. 2647-2657 11 p.

  Research output: Contribution to journal › Article › Academic › peer-review

  Open Access
  4 Citations (Scopus)

• Vedolizumab dalspiegels na subcutane toediening bij patiënten met inflammatoire darmziekten

  Translated title of the contribution: Vedolizumab trough levels during subcutaneous vedolizumab treatment in patients with inflammatory bowel diseasesDutch Initiative on Crohn and Colitis, 21 Apr 2023, In: Pharmaceutisch Weekblad. 158, 16, p. 23-30 8 p.

  Research output: Contribution to journal › Article › Professional
• 2022

  Real-world experience of switching from intravenous to subcutaneous vedolizumab maintenance treatment for inflammatory bowel diseases

  IBD center Amsterdam and the Dutch Initiative on Crohn and Colitis, Sept 2022, In: Alimentary Pharmacology and Therapeutics. 56, 6, p. 1044-1054 11 p.

  Research output: Contribution to journal › Article › Academic › peer-review

  Open Access
  19 Citations (Scopus)
• 2021

  Real-world clinical and endoscopic outcomes after one year tofacitinib treatment in ulcerative colitis

  Straatmijer, T., van Gennep, S., Duijvestein, M., Ponsioen, C. I. J., Gecse, K. B., D'Haens, G. R. & Löwenberg, M., 2021, In: European Journal of Gastroenterology & Hepatology. Publish Ahead of Print, p. 1288-1297 10 p.

  Research output: Contribution to journal › Article › Academic › peer-review
  13 Citations (Scopus)

• Ustekinuma b for Crohn's Disease: Two-Year Results of the Initiative on Crohn and Colitis (ICC) Registry, a Nationwide Prospective Observational Cohort Study

  Straatmijer, T., Biemans, V. B. C., Hoentjen, F., de Boer, N. K. H., Bodelier, A. G. L., Dijkstra, G., van Dop, W. A., Haans, J. J. L., Jansen, J. M., Maljaars, P. W. J., van der Marel, S., Oldenburg, B., Ponsioen, C. Y., Visschedijk, M. C., de Vries, A. C., West, R. L., van der Woude, C. J., Pierik, M., Duijvestein, M. & van der Meulen-de Jong, A. E., 1 Nov 2021, In: Journal of Crohn's and Colitis. 15, 11, p. 1920-1930 11 p.

  Research output: Contribution to journal › Article › Academic › peer-review

  Open Access
  21 Citations (Scopus)